Zacks.com on MSN2h
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales
Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...
ImmunityBio: Making Its Next Strikes After Bladder Cancer Approval
ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...
Zacks.com on MSN7h
IBRX Stock Soars on Completing Filing for Cancer Therapy in EU & UK
ImmunityBio IBRX shares rallied 27.2% on Thursday after it announced that it has completed the regulatory filing process in ...
Medscape10h
MRI Before Surgery Reduces Treatment Time for Muscle Invasive Bladder Cancer
Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...
Physics World12h
Could bubble-like microrobots be the drug delivery vehicles of the future?
The BAMs have a hydrophobic inner surface to prolong microbubble retention within biofluids and a hydrophilic outer layer ...
Irish Examiner21h
Working Life: Penile cancer is a rare form of cancer affecting around 60 men each year in Ireland
Alison Doran, clinical nurse specialist in penile and bladder cancer: "After a new diagnosis, I bring the patient and ...
tnp.straitstimes22h
Combo of ‘off-label’ chemo drugs successfully fights bladder cancer
A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time in Singapore. This new union of the two “off-label” drugs – gemcitabine and ...